结缔组织病相关性间质性肺病的肺移植治疗现状  

Updates in lung transplantation for connective tissue disease-associated interstitial lung disease

作　　者：刘虎 贺瑞卿 谢敏[2] LIU Hu;HE Rui-qing;XIE Min(Department of Pulmonary and Critical Care Medicine,Shanxi Bethune Hospital,Shanxi Taiyuan,030032,China;Department of Pulmonary and Critical Care Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Hubei Wuhan 430030,China)

机构地区：[1]山西白求恩医院(山西医学科学院)同济山西医院呼吸与危重症医学科,山西太原030032 [2]华中科技大学同济医学院附属同济医院呼吸与危重症医学科,湖北武汉430030

出　　处：《内科急危重症杂志》2024年第5期451-454,共4页Journal of Critical Care In Internal Medicine

摘　　要：肺移植是终末期肺病的重要救治手段,目前间质性肺疾病(ILD)接受肺移植的患者日益增多,但其中主要以特发性间质性肺炎为主,而结缔组织病相关间质性肺病(CTD-ILD)亦有大量终末期肺病患者,虽有肺移植的指征,但由于多器官受累,围手术期管理复杂,一直是肺移植领域的难点之一。本文总结了近年来CTD-ILD的肺移植相关治疗进展,以期对受体选择和围手术期管理等临床问题提供相关资料。Lung transplantation has become a crucial treatment option for patients with end-stage lung disease.In recent years,the number of patients with interstitial lung disease(ILD)undergoing lung transplantation has been steadily increasing,with the majority of these cases involving idiopathic interstitial pneumonia.However,connective tissue disease-related interstitial lung disease(CTD-ILD)also presents a significant number of patients with end-stage lung disease who meet the criteria for lung transplantation.Despite this,due to the involvement of multiple organs and the complexity of perioperative management,CTD-ILD remains one of the major challenges in the field of lung transplantation.This article reviews recent advancements in lung transplantation for CTD-ILD,aiming to provide relevant information on recipient selection and perioperative management for clinicians.

关 键 词：结缔组织病 间质性肺病 肺移植 

分 类 号：R563.13[医药卫生—呼吸系统]